---
trial_id: 309
discovery_date: 2022-04-02 17:30:16.006428
date: 2022-04-02 17:30:16.006428
title: "Intra-individual, randomized multicentric comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem in patients with Multiple Sclerosis at 3T"
summary: |
  <p>EudraCT Number: 2009-014857-34<br />Sponsor Protocol Number: FAU-001<br />Sponsor Name: Universitätsklinikum Erlangen<br />Start Date: 2010-02-01<br />Medical condition: Patients with clinically definite MS or a clinically isolated episode of CNS involvement and disease dissemination in space, according to the McDonald’s criteria<br />Disease: <br />Version: 12.0<br />SOC Term: <br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014857-34/DE">DE</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-014857-34'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2009-014857-34<br />Sponsor Protocol Number: FAU-001<br />Sponsor Name: Universitätsklinikum Erlangen<br />Start Date: 2010-02-01<br />Medical condition: Patients with clinically definite MS or a clinically isolated episode of CNS involvement and disease dissemination in space, according to the McDonald’s criteria<br />Disease: <br />Version: 12.0<br />SOC Term: <br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014857-34/DE">DE</a> (Completed)</p>